Is AstraZeneca buying Alexion?
Is AstraZeneca buying Alexion?
AstraZeneca today completed the acquisition of Alexion Pharmaceuticals, Inc. (Alexion). The closing of the acquisition marks the Company’s entry into medicines for rare diseases and the beginning of a new chapter for AstraZeneca.
What happened to Alexion Pharmaceuticals?
AstraZeneca closes mega $39B Alexion buyout despite antitrust fears, making a splash in rare diseases. AstraZeneca’s mega $39 billion takeover of Alexion Pharmaceuticals has come to a close, delivering the British pharma a lucrative portfolio of immunology medicines and a towering presence in rare diseases.
Who owns Alexion Pharmaceuticals?
AstraZeneca
Alexion Pharmaceuticals/Parent organizations
Why did AstraZeneca acquire Alexion?
AstraZeneca CEO Pascal Soriot said: “Alexion has established itself as a leader in complement biology, bringing life-changing benefits to patients with rare diseases. This acquisition allows us to enhance our presence in immunology. Upon completion of the deal, Alexion shareholders will own 15% of the combined company.
What is the Alexion deal?
The $39bn deal, announced in December 2020, is AstraZeneca’s largest ever acquisition: allowing it to move further into immunology with an enhanced scientific presence, and giving it Alexion’s lead medicine soliris (eculizumab), among four other approved medicines and a pipeline of 11 molecules.
What did AstraZeneca pay for Alexion?
New Jersey-based Caelum will become part of AstraZeneca’s Alexion division, the rare diseases specialist it bought for $39 billion earlier this year.
When did AstraZeneca acquire Alexion?
Who is CEO of Alexion?
Ludwig N. Hantson (Mar 2017–)
Alexion Pharmaceuticals/CEO
Ludwig N. Hantson, Ph. D., is Chief Executive Officer of Alexion. Dr. Hantson is an accomplished healthcare executive with more than 30 years of experience in the biopharmaceutical industry.
Is Alexion being sold?
AstraZeneca to Acquire Alexion, Accelerating the Company’s Strategic and Financial Development. CAMBRIDGE, England & BOSTON –(BUSINESS WIRE)–Dec. 12, 2020– AstraZeneca and Alexion Pharmaceuticals, Inc. ( Alexion ) have entered into a definitive agreement for AstraZeneca to acquire Alexion .
What is the stock symbol for Alexion?
ALXN
📉 ALEXION PHARMACEUTICALS INC Share Price – ALXN Share Price.
Who is buying Alexion?
AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push.
When did Alexion buys Portola?
On July 2, 2020 , Alexion completed its acquisition of Portola through the merger of Buyer with and into Portola without a vote of Portola’s shareholders pursuant to Section 251(h) of the Delaware General Corporation Law. As a result of the merger, Portola became a wholly owned subsidiary of Alexion .
